Article
Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor
24 Jul 2014
Abstract excerpt
UNLABELLED: Dengue viruses (DV) represent a significant global health burden, with up to 400 million infections every year and around 500,000 infected individuals developing life-threatening disease. In spite of attempts to develop vaccine candidates and antiviral drugs, there is a lack of approved therapeutics for the treatment of DV infection. We have previously reported the identification of ST-148, a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
